Monitoring risk factors and improving adherence to therapy in CKD patients. The SMIT-CKD project. (Preprint)

Author:

Vilasi Antonio,Panuccio Vincenzo,Morante Salvatore,Villa Antonino,Versace Maria Carmela,Mezzatesta Sabrina,Mercuri Sergio,Inguanta Rosalinda,Aiello Giuseppe,Cutrupi Demetrio,Puglisi Rossella,Capria Salvatore,Li Vigni Maurizio,Tripepi Giovanni,Torino ClaudiaORCID

Abstract

BACKGROUND

Chronic Kidney Disease is a major public health issue, with about 13% of the general adult population and 30% of the elderly affected. Patients in the last stage of this disease have an almost uniquely high risk of death and cardiovascular events, with reduced adherence to therapy representing an additional risk factor for cardiovascular morbidity and mortality. Considering the wide spreading of mobile phones, a mobile app could educate patients in self-monitoring cardio-renal risk factors.

OBJECTIVE

To develop an integrated system to educate patients in self-monitoring cardio-renal risk factors.

METHODS

We developed an integrated system made by a server and an app, with the aim of improving self-monitoring of cardiovascular and renal risk factors and of improving adherence to therapy.

RESULTS

The SMIT-CKD APP allows the monitoring of cardio-renal risk factors and their transmission to the referring GP. Special reminders help drug administration. Via the SMIT-CKD Server, GPs can monitor the clinical status of their patients and adherence to therapy. During the test, 73% of subjects entered all the required data regularly and sent feedbacks of drug intake. Looking at the evaluation questionnaires, both the app and the server counterpart were well accepted by the users.

CONCLUSIONS

Our study demonstrated that a simple Mobile APP, created to self-monitor modifiable cardio-renal risk factor and adherence to therapy, is well tolerated by patients affected by Chronic Kidney Disease. Further studies are required to clarify if the use of this integrated system will have long-term effects on therapy adherence, and if self-monitoring of risk factors will improve clinical outcomes in this population.

CLINICALTRIAL

NA

Publisher

JMIR Publications Inc.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3